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Summary
Background Konzo is an irreversible upper-motor neuron disorder affecting children dependent on bitter cassava for 
food. The neurocognitive ability of children with konzo over time has yet to be fully documented.
Methods We did a longitudinal study in a konzo outbreak zone continuously affected by konzo since 1990, in the district 
of Kahemba, southern Bandundu Province, Congo. We enrolled children with a record of neurological diagnosis of 
konzo in Kahemba town. For all study children with konzo enrolled in the final sample for the baseline assessment, a 
neurological exam was done by neurologists to confirm konzo diagnosis using the 1996 WHO criteria at 2 years and 
4 years. In the initial baseline sample for each child with konzo, we attempted to get consent from a comparison child 
without konzo (1996 WHO criteria) within 2 years of age, from a neighbouring household who met inclusion criteria. 
The neuropsychological assessments were the Kaufman Assessment Battery for Children, second edition (KABC-II), 
and the Bruininks-Oseretsky Test of Motor Proficiency, second edition (BOT-2).
Findings Data collection occurred between Oct 12, 2011, and Aug 14, 2015, in the town of Kahemba. 123 children from 
the Congo with konzo and 87 presumably healthy children without konzo from neighbouring households were 
enrolled. The planned assessments were completed by 76 children with konzo and 82 children without konzo at 
2-year follow-up, and by 55 children with konzo and 33 children without konzo at 4-year follow-up. Boys with konzo 
did worse than those without konzo on the KABC-II Learning (p=0·0424) and on the Mental Processing Index (MPI; 
p=0·0111) assessments at 2-year follow-up, but girls did not. These differences observed in boys might have been 
caused by stunting. At 4-year follow-up, the difference in KABC-II MPI score between boys or girls with or without 
konzo was not significant. Both boys and girls with konzo had lower scores on BOT-2 than children without konzo at 
both follow-up times (p<0·0001). These differences were not attenuated when controlling for physical growth. Boys 
with and without konzo declined on BOT-2 fine motor proficiency at 2-year follow-up (boys with konzo p=0·0076; 
boys without konzo p=0·0224) and KABC-II MPI performance at 2-year follow-up and 4-year follow-up (2 years: boys 
with konzo p<0·0001, boys without konzo p=0·0213; 4 years: boys with konzo p=0·0256, boys without konzo p=0·10), 
but that was not the case for the girls with scores remaining stable regardless of konzo status. For boys, increases in 
urinary thiocyanate concentration was significantly associated with reductions in BOT-2 motor proficiency (p=0·0321), 
but was not significantly associated in girls and urinary thiocyanate concentration was not associated with KABC-II 
MPI score for either boys or girls.
Interpretation Motor and cognitive performance continues to be significantly impaired in boys with konzo at 2-year 
follow-up compared with boys without konzo. Because these impairments are associated in part with exposure to 
poorly processed cassava as measured by urinary thiocyanate, interventions are urgently needed to ensure improved 
processing of cassava to detoxify this food source.
Funding US National Institutes of Health. 
Copyright © The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license.
Introduction
Konzo is defined by WHO as a visible symmetric spastic 
abnormality of gait while walking or running in a formerly 
healthy person with a history of onset of less than 1 week. 
After onset, a non-progressive course follows and bilaterally 
exaggerated knee or ankle jerks without signs of disease of 
the spine.1 The disease results from subsisting on poorly 
processed cassava, which has a high toxicity from its 
cyanogenic glycosidic content.2 Because konzo appears to 
be a pure upper-motor neuron disorder, cognitive effects 
were originally deemed absent or minimal.1,3
We contradicted the assumption that cognitive effects 
were absent or minimal in our 2013 study4 when we 
documented children with konzo, from a konzo outbreak 
zone in the Congo, did more poorly than children without 
konzo on cognitive tests of visual–spatial analysis and 
problem solving.4 This observation was especially true for 
the boys in the sample. However, boys with konzo were 
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also less likely to be enrolled in school, perhaps because 
of social stigma associated with the disorder, and this 
factor could also contribute to their worse cognitive 
performance. Both boys and girls with and without 
konzo from households with konzo did worse on 
memory tests than children without konzo from an area 
in that region without a konzo outbreak.
Konzo occurs primarily in extremely impoverished 
communities who subsist on high-yield varieties of poorly 
processed bitter cassava with little protein in their diet in 
times of food insecurity and near-famine conditions.2 
Therefore, in comparing both children with and without 
konzo overall from outbreak and non-outbreak zones 
dependent on cassava, neurocognitive differences due to 
extreme poverty might overshadow the effects of 
cyanogenic toxic exposure itself in poorly processed 
cassava. In their review, Tylleskar and Tshala-Katumbay2 
provide a thorough list of studies of the epidemiology, 
causes, progression, and prognosis of konzo disease. One 
study5 did a follow-up evaluation with patients with konso 
in Mozambique, and concluded that the paralysis was not 
worsening and that there were some improvements in 
mobility during the 14 years of follow-up after konzo 
onset. However, the improved mobility did not seem to be 
the result of an actual improvement in the neurological 
condition of the patients. Rather, improvements in 
mobility were probably the result of patients adapting to 
their paresis. A follow-up study on the mobility of patients 
with konzo is not the same as a follow-up on disease 
progression, and studies have typically not been able to 
meaningfully evaluate the neuropathophysiological 
progression of konzo disease with human beings in the 
field. Therefore, changes in the neurocognitive and 
neuromotor proficiency of children with konzo are 
unknown, and the pathophysiological and neurological 
progression of the disease itself in such children over 
time is completely unknown.
This study is a follow-up evaluation of cognitive and 
motor proficiency in the same cohorts of children with 
and without konzo observed in our 2013 study,4 2 years 
and 4 years after the baseline evaluations. In these follow-
up assessments, we continued to monitor the cognitive 
and motor proficiency differences between the cohorts 
with and without konzo, and to see whether decline in 
these proficiencies is observable over time for either or 
both groups. Furthermore, we have stratified the cohorts 
by gender to verify whether boys with konzo are still at 
greater risk than their counterparts without konzo, as 
compared with the girls. Finally, we further assessed the 
overall effect of their socioeconomic conditions and their 
quality of home environment on the cognitive and motor 
proficiency outcomes.
Methods
Study design and participants
The study site was a konzo outbreak zone continuously 
affected by konzo since 1990,6 in the district of Kahemba, 
southern Bandundu Province, Congo. The data collection 
Research in context
Evidence before this study
Our preceding study provided the baseline assessment to the 
present one, and was the only study that we could find that 
evaluated the neuropsychological, neurodevelopmental, 
cognitive, or motor proficiency effects of konzo. This was 
confirmed by doing a keyword search for these terms in relation 
to konzo using PubMed and MEDLINE with no date or language 
restrictions. Previous electrophysiological studies of konzo 
disease patients using electroencephalogram (EEG), evoked 
potential EEG, and electromyography (EMG) implicated higher 
brain centres as being involved in the disease. Again, the only 
study of the brain effects of konzo was in a few adult Tanzanian 
patients with konzo brought to Sweden for MRI imaging. 
However, no clear evidence emerged for konzo effects in terms 
of brain structure.
Added value of this study
The present study documents the presence of a possible 
subclinical condition in children without konzo, seemingly on 
the threshold of neuropsychological impairment from ongoing 
exposure to poorly processed cassava in affected communities. 
In a longitudinal assessment over 4 years, we provide the first 
evidence that there is continued neurocognitive and 
neuromotor decline in children with and without konzo, 
especially boys, in affected households.
Implications of all the available evidence
Cassava is a crop of subsistence for more than 600 million 
people around the world and particularly in many tropical 
regions. Much of the Congo basin in central Africa will continue 
to rely on cyanogenic cassava as an important source of food, 
thus putting millions of children at risk for 
neurodevelopmental disabilities from exposure to toxic 
cassava. Therefore, useful tools for monitoring 
pathophysiological exposure to toxic cassava and risk for 
konzo are of vital importance. Urinary thiocyanate, used in the 
present study, is a useful and practical indicator of recent 
exposure to poorly processed cassava in the field setting. 
However, its validity and utility for documenting past acute 
exposure and cumulative exposure over time are very limited. 
Sensitive and specific biomarkers for the disease process in 
konzo that are feasible for field-surveillance programmes are 
desperately needed. Such sensitive and practical biomarker 
tests for konzo risk should be coupled with community-wide 
household-based health education and promotion for the safe 
processing of cassava, such as the wetting method presently 
being implemented in especially at-risk health zones in the 
western Congo. Prevention is still the key for an effective 
public health response to konzo in Africa.
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occurred between Oct 12, 2011, and Aug 14, 2015, in the 
town of Kahemba.
From earlier outbreaks in Kahemba, 5000 participants 
in Kahemba town had been included on a WHO 
surveillance list, of which about half were children 
(younger than 18 years of age). From this list, we were 
able to locate 308 children with a record of neurological 
diagnosis of konzo in Kahemba town, of which 
123 children with konzo were randomly selected for 
study participation (65 boys, 58 girls; mean age 8·7 years, 
range 4–17).4 For all study children with konzo enrolled in 
the final sample for the baseline assessment, a 
neurological exam was again performed by neurologists 
on our assessment team (DO, BM-M, and M-TS) to 
confirm konzo diagnosis using the 1996 WHO criteria at 
2 years and 4 years.1 In the initial baseline sample for 
each child with konzo, we attempted to get consent from 
a comparison child without konzo (1996 WHO criteria) 
within 2 years of age from a neighbouring household 
who met inclusion criteria.4
The Ministry of Health for the Congo and the 
institutional review board (IRB) for the ethical conduct of 
human participant research for Oregon Health and 
Sciences University provided study approval. Caregivers 
of study children gave oral consent in the local language 
and with signature or thumbprint for those who were 
illiterate.
Procedures
All the following measures in the present follow-up 
assessments were used in the original testing of the study 
children at baseline.4 All cognitive, motor proficiency, and 
neurological assessments at all three timepoints (baseline, 
2 years, 4 years) were done by the same three co-authors 
who are neurologists (DO, BM-M, M-TS) trained in the 
Kaufman Assessment Battery for Children, second edition 
(KABC-II) and Bruininks/Oseretsky Test of Motor 
Proficiency (second edition; BOT-2), reducing the inter-
rater variability. Community health workers (nurses) 
from the Ministry of Health were trained to complete the 
Caldwell Home Observation for the Measurement of the 
Environment (HOME)7 and socioeconomic status 
measures in the home after the consent process,8–10 and 
these were completed before the other cognitive and 
motor assessments. Details of the HOME, KABC-II, and 
BOT-2 and how they were applied are in the appendix. 
Both the KABC-II and BOT-2 were used in this follow-up 
assessment because they also proved sensitive to 
metabolic biomarkers of cyanide exposure from poorly 
processed cassava in the baseline assessment.11–13
Urinary thiocyanate (Bradbury kit, Australian Centre 
for International Agricultural Research, Australian 
National University, Acton, ACT, Australia) was also 
measured in all study children at baseline and again at 
4-year follow-up as a toxin exposure biomarker for recent 
exposure (in the past week or so) to poorly processed 
cassava. As such, this measure is only a general indication 
of cassava processing practices in the household at that 
time, and cannot be considered a sensitive biomarker to 
past exposure or cumulative exposure to poorly processed 
cassava.13,14 Baseline urinary thiocyanate was assessed for 
the groups with konzo (mean 519 μmol/L, SD 354) and 
without konzo (mean 389 μmol/L, SD 224). These 
concentrations represent high cyanogenic exposure in 
both groups for this time of year, based on earlier studies 
by Banea and colleagues15,16 of thiocyanate levels among 
konzo-affected populations in this region. This indicates 
that exposure to poorly processed cassava in general for 
cohort households with or without konzo was high, 
suggesting that all the children in this community could 
be at risk for konzo.
Outcomes
The main outcomes of the study were motor proficiency 
as measured by the BOT-2 Total Motor performance 
score and scales (fine manual, manual coordination, 
body coordination, strength, and agility), and cognitive 
ability as measured by the KABC-II mental processing 
index (MPI) score and scales (sequential processing, 
simultaneous processing, learning, planning, and 
delayed recall). 
Statistical analysis
We used the Kruskal–Wallis one-way ANOVA, χ², or 
Fisher’s exact tests for cross-sectional comparisons of 
participants with konzo versus without konzo. Three 
repeated measures of BOT-2 and KABC-II scores were 
analysed using generalised linear mixed effects models. 
Generalised linear mixed effects modelling generalises 
classical analysis of repeated measures and allows for 
data missing at random, structured covariance matrix, 
and non-Gaussian error distribution. Non-independence 
of observations due to repeated measures is accounted 
for by including the corresponding random effect in the 
model. Because the distributions of outcomes were 
highly skewed to the right, we specified log link function 
and gamma distribution in generalised linear mixed 
effects models. Based on previously published results,4 
we stratified the analyses by a child’s sex. Adjusted means 
of the logarithms of outcome variables and 95% CIs for 
them were output from generalised linear mixed effects 
models. The means were back transformed to the 
original scale by exponentiation. To gauge clinical 
significance of findings, we computed standardised 
mean differences (SMDs) as differences between 
adjusted means of the outcomes for children with konzo 
versus without konzo divided by the standard deviation 
of the children without konzo at baseline, separately for 
each sex. We used SAS version 9.4 for statistical analyses.
Because konzo is a disease that arises out of extreme 
poverty, we repeated the analyses comparing children 
with konzo to those without konzo, controlling for 
physical growth that could be affected by malnutrition, 
so that the effect of konzo disease itself could be better 
See Online for appendix
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evaluated. We added standardised height-for-age Z scores 
and weight-for age Z scores at baseline to the generalised 
linear mixed effects models, and evaluated the effects of 
their addition on konzo versus non-konzo group 
differences. The significance of the association between 
these physical growth measures with motor and cognitive 
outcomes, and the attenuation of konzo versus nonkonzo 
group differences when controlling for height-for-age 
z-scores and weight-for age z-scores were used to evaluate 
the mediational role of stunting and wasting on the 
BOT-2 motor proficiency and KABC-II cognitive 
performance principal outcomes.
Because the Caldwell HOME scale and socioeconomic 
status are strongly correlated, inclusion of only one of 
them avoids the problem of collinearity. Maternal literacy 
is included in the socioeconomic status measure, which 
is strongly associated with the Caldwell HOME score. In 
the present analyses, we adjusted for Caldwell HOME 
score because it differed at baseline between the children 
with and without konzo, whereas socioeconomic status 
score did not (table 1). Likewise, the number of children 
with konzo lost to follow-up differed significantly from 
those we were able to assess in terms of HOME score, so 
this was another reason it was important to adjust for it, 
rather than adjust for socioeconomic score.
Role of the funding source
The study sponsor had no role in the design and conduct 
of the study; collection, management, analysis, and 
interpretation of the data; and preparation, review, or 
approval of the manuscript. The lead author (MJB) and 
study statistician (AS) have complete access to the study 
data and are responsible for the reported study findings, 
and along with the study principal investigator (DT-K) 
made the decision to submit for publication.
Results
210 children (median age 8·38 years, IQR 6·92–10·58) 
completed the first neurocognitive assessment, 
117 completed a follow-up assessment approximately 
2 years later (median age 10·09 years, IQR 8·67–12·27), 
and 89 completed another follow-up assessment 2 years 
later (median age 11·97 years, IQR 10·55–14·14). Results of 
a diagnostic neurological exam for konzo at 2-year follow-
up were available for 116 (99%) of 117 children. Four 
children (three boys, one girl) without konzo at baseline 
developed the disease by 2-year follow-up. Another male 
child developed konzo between the 2-year follow-up and 
4-year follow-up. These five children were excluded from 
the longitudinal analysis that focused on the effects of 
konzo over time. Table 1 presents characteristics of 
children who were analysed (123 children with konzo, 
87 children without konzo). Baseline outcome scores or 
physical growth measures (height-for-age Z scores and 
weight-for age Z scores) of those who did not complete 
later assessments were not different from those who did 
(appendix).
As previously reported,4 at intake and throughout 
follow-up, children with konzo and without konzo were 
similar in age, gender composition, and socioeconomic 
status (table 1). Among children without konzo, 91% of 
girls and 88% of boys were enrolled in school at baseline. 
The corresponding percentages of children with konzo 
enrolled in school were 59% of girls and 60% of boys, 
with no differences by sex. Children with konzo were 
significantly below those without konzo in terms 
of height and weight, and height and weight for 
children with konzo was also less than the normal 
95% CI normative range provided by the Centers for 
Disease Control and Prevention (CDC). Children with 
konzo also scored lower on the Caldwell HOME scale 
With konzo Without konzo p value
Baseline
Number of patients 123 82 ··
Age (years) 8·7 (2·5) 9·1 (2·6) 0·21
Sex (female) 58 (41%) 34 (47%) 0·47*
Enrolled in school 73 (59%) 73 (89%) 0·0001*
School grade level 1·3 (1·6) 2·5 (1·9) 0·0010
Caregiver with konzo 99 (81%) 58 (66%) 0·0216*
Other family with konzo 85 (85%) 61 (70%) 0·0075*
Weight for age (CDC Z score†) –2·9 (–1·0) –2·1 (1·5) <0·0001
Height for Age (CDC Z score†) –3·4 (1·4) –2·3 (1·8) <0·0001
Caldwell HOME score total‡ 43·5 (8·1) 47·2 (10·4) 0·0040
Socioeconomic status score§ 2·2 (1·1) 2·8 (3·2) 0·07
Neurological index Score¶ 11·4 (4·4) 2·0 (1·7) <0·0001
Urinary thiocyanate (μmol/mL) 519 (354) 389 (224) 0·0060
2 years
Number of patients 76 36 ··
Age (years) 10·2 (2·4) 10·8 (2·4) 0·44
Sex (female) 35 (46%) 12 (33%) 0·22
Weight for age (WHO Z score†) –3·8 (1·3) –2·3 (1·4) <0·0001
Height for age (WHO Z score†) –3·1 (1·4) –1·7 (1·5) <0·0001
Caldwell HOME score total‡ 45·2 (7·2) 49·2 (11·8) 0·06
Neurological index score¶ 12·4 (4·8) 1·3 (1·9) <0·0001
4 years
Number of patients 55 33 ··
Age (years) 11·9 (2·1) 12·0 (2·2) 0·85
Sex (female) 26 (47%) 14 (42%) 0·83
Weight for age (WHO Z score†) –3·8 (1·6) –2·0 (0·7) <0·0001
Height for age (WHO Z score†) –3·7 (1·8) –2·2 (1·7) <0·0001
Caldwell HOME score total‡ 45·5 (8·0) 49·5 (10·8) 0·05
Urinary thiocyanate (μmol/mL) 1056 (577) 1098 (572) 0·44
Data are mean (SD) or n (%). p values are based on Kruskal-Wallis ANOVA test unless otherwise specified. CDC=Centers 
for Disease Control and Prevention. *p values for χ² statistic between categories (gender, enrolled in school). †Z score 
values are from CDC 2000 norms from Epi Info at baseline and from WHO at 2 years and 4 years. ‡Based on the Caldwell 
Home Observation for the Measurement of the Environment (HOME) total score. §The socioeconomic status score is 
measured by assessing the physical characteristics of home dwelling and material and animal possessions during a visit 
to the home. ¶Children with konzo and children without konzo were assessed for upper-motor neuron signs, which are 
characteristic of konzo. From this exam we computed a total score reflecting the neurological impairment pertaining to 
konzo. For each of the neurological signs listed in table 1 index, children were scored as either normal (0 points), mildly 
abnormal (1 point), or moderately or severely abnormal (2 points).
Table 1: Patients characteristics
For more on Epi Info see 
https://www.cdc.gov.epiinfo/
index.html
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(measuring quality of caregiving) at baseline and at 
2-year and 4-year follow-ups.
For boys (table 2) and girls (table 3), children with 
konzo had significantly lower scores on all scales of 
motor proficiency assessed by BOT-2 scale than did 
children without konzo at baseline, at 2-year follow-up, 
and at 4-year follow-up, except on the fine manual scale. 
SMDs of more than 1 indicated a difference of more than 
1 SD between the children with and without konzo at 
baseline. For KABC-II, boys with konzo had significantly 
lower MPI scores than boys without konzo (p=0·0111) at 
2-year follow-up, but not at baseline or 4-year follow-up 
(table 4), and the SMD for MPI reduced between 2-year 
follow-up and 4-year follow-up but remained more than a 
third of the SD, a threshold sometimes used for clinical 
significance.17 Among girls, the SMD for MPI was low at 
baseline and 2-year follow-up but increased to 0·54 at 
4-year follow-up (table 5). Boys with konzo scored 
significantly lower on the KABC-II learning domain 
(p=0·04424) and the KABC-II Planning domain 
(p=0.0056) at 2-year follow-up, than boys without konzo, 
but not at 4 years. KABC-II scores were not significantly 
different between girls with and without konzo at all 
three timepoints, with SMDs also not indicating clinically 
meaningful differences except for the planning domain 
at both follow-up times (table 5).
Examination of the adjusted means reported in 
tables 2–5 within each group over time indicates that at 
2-year follow-up boys with konzo significantly declined 
from baseline on BOT-2 fine manual scores (p=0·0076) 
and body coordination scores (p=0·0277). Whereas, boys 
without konzo declined only on fine manual scores 
(p=0·0224). Boys with konzo also declined significantly 
on KABC-II MPI (p<0·0001), sequential processing 
(p<0·0001), learning (p=0·0023), and delayed recall 
scores (p=0·0037). The boys without konzo declined 
significantly on KABC-II MPI (p=0·0213), sequential 
processing (p<0·0001), and simultaneous processing 
(p=0·05), although these findings should not be given a 
strong interpretation due to the large number of tests, 
which could increase the chance of finding a false 
positive. No significant BOT-2 or KABC-II changes were 
apparent between baseline and 2-year follow-up for girls 
with and without konzo.
At 4-year follow-up, boys with konzo significantly 
declined from baseline on fine manual (p=0·0088) and 
Baseline 2 years 4 years
Without konzo With konzo p value SMD Without konzo With konzo p value SMD Without konzo With konzo p value SMD
Total motor 37·03 
(34·91–39·28)
26·87 
(25·43–28·38)
<0·0001 1·46 37·09 
(34·31–40·09)
25·44 
(23·90–27·07)
<0·0001 1·67 36·15 
(32·94–39·67)
25·99 
(24·11–28·01)
<0·0001 1·46
Fine manual 37·91 
(36·62–40·35)
34·41 
(32·48–36·46)
0·0239 0·38 34·09 
(31·31–37·12)
31·02 
(28·99, 33·20)
0·0405 0·33 35·22 
(31·83–38·98)
31·24 
(28·79–33·91)
0·06 0·43
Manual coordination 38·60 
(36·10–41·26)
29·88 
(28·07–31·80)
<0·0001 1·15 38·09 
(34·93–41·55)
28·15 
(26·26–30·19)
<0·0001 1·31 42·77 
(38·56–47·45)
31·57 
(29·04–34·33)
<0·0001 1·48
Body coordination 42·12 
(39·45– 44·97)
27·69 
(26·06–29·43)
<0·0001 1·71 42·85 
(39·22–46·82)
25·39 
(23·66–27·25)
<0·0001 2·07 41·57 
(37·41–46·19)
25·15 
(23·10–27·38)
<0·0001 1·95
Strength agility 39·76 
(37·34–42·35)
27·13 
(25·58–28·76)
<0·0001 1·83 42·65 
(39·24–46·36)
26·33 
(24·63–28·15)
<0·0001 2·37 37·94 
(34·35–41·91)
25·7 
 (23·75–27·89)
<0·0001 1·77
Data are means adjusted for child’s age and Caldwell HOME scale quality of caregiving environment, presented with 95% CI below the adjusted mean and SMDs after the p value of the ANCOVA between-group 
comparison. SMDs of more than 1 indicated a difference of more than 1 SD between the children with and without konzo at baseline. BOT-2=Bruininks-Oseretsky Test of Motor Proficiency, 2nd edition. 
HOME=Home Observation for the Measurement of the Environment. SMD=standardised mean differences.
Table 2: Comparison of boys with and without konzo on the BOT-2 scale of motor proficiency at baseline, 2 years, and 4 years
Baseline 2 years 4 years
Without konzo With konzo p value SMD Without konzo With konzo p value SMD Without konzo With konzo p value SMD
Total motor 32·42 
(30·31–34·69)
22·68 
(31·83–38·82)
<0·0001 1·35 35·15 
(31·83–38·82)
22·40 
(21·06–23·83)
<0·0001 1·77 33·07 
(29·63–36·92)
22·99 
(21·19–24·93)
<0·0001 1·4
Fine manual 28·69 
(26·60–30·94)
26·20 
(24·69–27·80)
0·05 0·33 30·22 
(27·24–33·52)
25·80 
(24·14–27·57)
0·0125 0·59 28·74 
(25·68–32·15)
26·65 
(24·46–29·04)
0·25 0·28
Manual coordination 33·66 
(31·14–36·39)
25·24 
(23·75–26·83)
<0·0001 1·16 36·36 
(32·56–40·60)
25·19 
(23·49–27·01)
<0·0001 1·55 37·92 
(33·68–42·71)
27·99 
(25·58–30·63)
<0·0001 1·38
Body coordination 38·77 
(36·18–41·54)
24·18 
(22·90–25·52)
<0·0001 1·92 41·14 
(37·08–45·64)
22·75 
(21·34–24·25)
<0·0001 2·22 41·46 
(37·11–46·32)
23·22 
(21·37–25·22)
<0·0001 2·21
Strength agility 37·69 
(35·02–40·57)
24·36 
(23·00–25·81)
<0·0001 1·79 42·73 
(38·18–47·83)
24·32 
(22·69–26·05)
<0·0001 2·47 39·70 
(35·21–44·76)
23·36 
(21·37–25·55)
<0·0001 2·19
Data are means adjusted for child’s age and Caldwell HOME scale quality of caregiving environment, presented with 95% CI below the adjusted mean and SMDs after the p value of the ANCOVA between-group 
comparison. BOT-2=Bruininks-Oseretsky Test of Motor Proficiency, 2nd edition. HOME=Home Observation for the Measurement of the Environment. SMD=standardised mean differences.
Table 3: Comparison of girls with and without konzo on the BOT-2 scale of motor proficiency at baseline, 2  years, and 4 years
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body coordination (p=0·0432) BOT-2 scales, and the 
KABC-II MPI composite (p=0·0256) and delayed 
(p=0·0037) recall global measures. No significant declines 
were evident for boys without konzo, nor were there 
significant declines for the girls with and without konzo 
from baseline to 4-year follow-up. In fact, girls improved 
on some of the KABC-II measures, but this finding might 
not be reliable due to a relatively small sample size at 
4-year follow-up in terms of statistical power.
Urinary thiocyanate concentration was significantly 
higher in children with konzo than children without konzo 
at baseline, but did not differ significantly at 4-year follow-
up (table 1). However, urinary thiocyanate concentration 
significantly increased from baseline to 4-year follow-up in 
children with and without konzo (p=0·0080).
The greater the increase in thiocyanate exposure, the 
poorer the motor proficiency (figure 1). Change in urinary 
thiocyanate concentration in boys (with and without 
konzo) from baseline to 4-year follow-up was significantly 
associated with change in BOT-2 total motor proficiency 
score from baseline to 4-year follow-up (r=–0·39, n=47, 
p=0·0321; figure 2). There was not a significant regression 
association in girls (r=0·10, n=33, p=0·71; figure 2). 
Change in urinary thiocyanate concentration was not 
significantly associated with KABC-II MPI score for boys 
(r=–0·15, n=50, p=0·42; figure 3), or girls (r=0·14, n=41, 
p=0·55; figure 3). 
The evaluation of the potential mediational roles of 
height-for-age Z scores and weight-for-age Z scores for 
BOT-2 and KABC-II principal outcomes is in the 
appendix. In brief, when adding weight-for age z-scores 
as a covariate, the findings presented in tables 2–5 in 
terms of the differences between children with and 
without konzo did not change in any appreciable way. 
However, in terms of its covariate main effect across both 
konzo groups and across all three time points, weight-
for-age z-score was significantly associated with BOT-2 
fine manual motor proficiency scores for both sexes 
(boys: β=0·034, SE=0·013, t(108)=2·52, p=0·0130; girls: 
β=0·044, SE=0·022, t(87)=2·03, p=0·0463) and 
Baseline 2 years 4 years
Without konzo With konzo p value SMD Without konzo With konzo p value SMD Without konzo With konzo p value SMD
Mental processing 
index
64·13 
(61·68–66·68)
61·04 
(58·87–63·28)
0·06 0·34 60·07 
(56·98–63·32)
55·08 
(52·90–57·34)
0·0111 0·56 60·74 
(57·12–64·58)
57·23 
(54·48–60·13)
0·11 0·39
Sequential processing 75·23 
(71·94–78·66)
72·86 
(69·91–75·95)
0·29 0·18 69·56 
(65·52–73·85)
65·56 
(62·62–68·63)
0·12 0·31 74·17 
(69·19–79·52)
69·35 
(65·61–73·31)
0·11 0·37
Simultaneous 
processing
69·17 
(65·52–73·01)
64·73 
(61·58–68·04)
0·08 0·41 64·28 
(59·75–69·15)
61·14 
(57·81–64·65)
0·28 0·29 67·17 
(61·38–73·51)
64·03 
(59·47–68·94)
0·39 0·29
Learning 70·48 
(67·33–73·79)
69·75 
(66·84–72·78)
0·74 0·07 69·78 
(66·84–72·78)
64·40 
(61·45–67·50)
0·0424 0·52 66·16 
(61·60–71·04)
65·60 
(61·97–69·44)
0·84 0·05
Planning 61·53 
(58·74–64·46)
56·19 
(53·81–58·69)
0·0056 0·48 57·41 
(54·24–60·76)
55·07 
(52·63–57·62)
0·26 0·21 59·06 
(55·36–63·01)
55·98 
(53·00–59·13)
0·20 0·28
Delayed recall 73·01 
(70·09–76·05)
74·47 
(71·71–77·33)
0·47 0·06 70·28 
(66·39, 74·41)
69·32 
(66·46, 72·31)
0·70 0·10 70·57 
(65·88–75·59)
68·45 
(64·88–72·23)
0·47 0·23
Data are means adjusted for child’s age and Caldwell HOME scale quality of caregiving environment, presented with 95% CI below the adjusted mean and SMDs after the p value of the ANCOVA between-group 
comparison. HOME=Home Observation for the Measurement of the Environment. KABC-II=Kaufman Assessment Battery for Children, second edition. SMD=standardised mean differences.
Table 4: Comparison of boys with and without konzo on the KABC-II Learning and Mental Processing Index scale at baseline, 2 years, and 4 years
Baseline 2 years 4 years
Without konzo With konzo p value SMD Without konzo With konzo p value SMD Without konzo With konzo p value SMD
Mental processing 
index
56·45 
(53·85–59·17)
55·37 
(53·37–57·44)
0·51 0·13 55·71 
(51·72–60·00)
55·22 
(52·83–57·72)
0·84 0·06 63·58 
(59·11–68·39)
59·18 
(56·01–62·54)
0·10 0·54
Sequential processing 70·85 
(66·81–75·13)
67·02 
(64·01–70·17)
0·13 0·26 65·55 
(60·02–71·60)
67·68 
(64·01–70·17)
0·54 0·15 75·63 
(69·24–82·61)
73·80 
(68·88–79·08)
0·64 0·13
Simultaneous 
processing
55·81 
(52·25–59·62)
55·10 
(52·36–57·98)
0·76 0·08 56·80 
(50·97–63·30)
57·70 
(54·09–61·56)
0·80 0·10 59·54 
(51·60– 68·70)
57·70 
(52·44–63·50)
0·71 0·19
Learning 68·51 
(64·94–72·28)
66·54 
(63·82–69·38)
0·37 0·20 62·74 
(57·76–68·16)
63·81 
(60·70–67·07)
0·73 0·11 69·49 
(64·02–75·43)
66·74 
(62·60–71·17)
0·41 0·28
Planning 54·82 
(52·51–57·22)
54·36 
(52·57–56·21)
0·76 0·07 57·53 
(54·05– 61·23)
53·92 
(51·95–55·96)
0·08 0·57 60·43 
(56·77–64·32)
57·64 
(54·94–60·48)
0·22 0·44
Delayed recall 71·17 
(67·76–74·76)
69·65 
(67·04–72·36)
0·48 0·16 69·45 
(64·28–75·03)
67·88 
(64·84–71·08)
0·61 0·16 69·81 
(64·40–75·68)
67·93 
(63·81–72·32)
0·57 0·20
Data are means adjusted for child’s age and Caldwell HOME scale quality of caregiving environment, presented with 95% CI below the adjusted mean and SMDs after the p value of the ANCOVA between-group 
comparison. HOME=Home Observation for the Measurement of the Environment. KABC-II=Kaufman Assessment Battery for Children, second edition. SMD=standardised mean differences.
Table 5:  Comparison of girls with and without konzo on the KABC-II Learning and Mental Processing Index scale at baseline, 2 years, and 4 years
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significantly correlated with KABC-II simultaneous 
processing (visual–spatial analysis and problem solving) 
for boys (boys: β=0·026, SE=0·012, t(108)=2·18, 
p=0·0321). Controlling for height-for-age Z scores at 
baseline did not change the differences between children 
with and without konzo for BOT-2 outcomes (table 2 
and 3), despite the fact that height-for-age Z score itself 
was significantly associated with all BOT-2 outcomes. 
Controlling for height-for-age Z scores when we analysed 
KABC-II scores resulted in the attenuation of the 
few significant between-group differences for the boys in 
table 4 (appendix).
Discussion
On the BOT-2 assessment of motor proficiency, both 
boys and girls with konzo did significantly worse than 
children without konzo at 2-year and 4-year follow-up. 
The mean differences between the groups were 
consistent with those apparent at baseline, with SMD 
exceeding 1. This effect was not mediated by wasting 
(weight-for-age Z score) or stunting (height-for-age Z 
score), but seemed to be primarily the result of konzo 
status. The only exception was the BOT-2 fine manual 
motor scale, which is consistent with the well-
documented effects of konzo primarily affecting the 
lower limbs, as opposed to the arms and hands.2 
However, in terms of decline from baseline to 2-year 
follow-up, the largest declines for boys both with and 
without konzo were for BOT-2 fine manual motor 
proficiency. Notably, wasting, which can be taken as an 
indicator of more recent nutritional hardship,18 was 
significantly correlated with BOT-2 fine manual motor 
proficiency for both sexes. This result suggests that 
changes in this motor proficiency domain over time 
might be the result of malnutrition, rather than the direct 
results of konzo disease progression per se.
Although some reviews of konzo19 have reported 
neurological relapse in patients with konzo, our reported 
declines in proficiency as measured by BOT-2 motor 
proficiency cannot be interpreted as the result of relapse, 
which would be characterised by more abrupt 
neurological re-emergence and onset. In statistically 
evaluating these comparisons, we used generalised 
linear mixed effects modelling to account for the non-
independence of the BOT-2 repeated measure outcomes, 
as well as to control for the baseline between-group 
HOME differences among children with and without 
konzo, and those retained and those lost to follow-up via 
the missing at random mechanism. Although not 
directly testable, the missing at random mechanism was 
supported by the attrition analyses.
BOT-2 motor proficiency decline from baseline to 
4-year follow-up was associated with increases in urinary 
thiocyanate concentration from baseline to 4-year follow-
up in boys with and without konzo, but not in girls. 
Furthermore, increases in urinary thiocyanate con-
centration in boys and girls with and without konzo were 
not associated with changes in KABC-II MPI 
performance (a composite of overall cognitive ability). 
The absence of statistical significance at 4-year follow-up 
might be due to a smaller sample size at this point, 
especially for the children without konzo: a serious 
limitation in our present study. However, notably, 
although urinary thiocyanate concentration is useful as a 
biomarker of recent exposure to poorly processed 
cassava, it is not a sensitive biomarker for past acute toxic 
exposure that might have resulted in the abrupt onset of 
neurological konzo disease, or cumulative exposure that 
could have long-term neurocognitive and neuromotor 
effects. Serum-based biomarkers are needed that are 
Figure 1: Change in urinary thiocyanate and (A) change in BOT-2 of motor proficiency standard total score 
and (B) change in KABC-II MPI score for children with konzo from baseline to 4-year follow-up
Girls are depicted in blue along with the linear least square fit line and function, and boys are depicted in red. 
BOT-2=Bruininks-Oseretsky Test, second edition. KABC-II=Kaufman Assessment Battery for Children, 
second edition. MPI=Mental Processing Index.
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sensitive to metabolic processes that might in fact 
mediate the neuropathic pathways of cyanogenic toxicity 
in the brain, especially biomarkers that measure 
cumulative past exposure over time.
Mean differences in KABC-II cognitive ability 
performance between boys with and without konzo were 
also consistent from baseline to 2-year and 4-year follow-
up, between a third to just more than half of the standard 
deviation of children without konzo at baseline. The boys 
without konzo also exhibited significant decline in this 
measure from baseline to 2-year follow-up, especially on 
KABC-II sequential processing, which is a measure of 
visual and auditory working memory. The original 
baseline findings also documented significant KABC-II 
cognitive deficits for this global domain for children 
without konzo, suggesting the possibility that this disease 
might be associated with a subclinical neurocognitive 
deficit.4 Although it is generally known how konzo 
progresses neurologically,2 it is unknown whether the 
discernable neurological upper-motor neuron disease is 
directly associated neurocognitive impairment. In the 
present study we have documented continuing neuro-
cognitive disability in boys with konzo compared with 
their counterparts without konzo in follow-up. However, 
it is important to qualify our findings by stating that we 
do not have field-worthy sensitive and specific biomarkers 
Figure 2: Change in BOT-2 total motor proficiency and change in urinary thiocyanate between baseline and 4-year follow up
Change in urinary thiocyanate and change in BOT-2 of motor proficiency standard total score in (A) boys with konzo and (B) girls with konzo. BOT-2=Bruininks-
Oseretsky Test, seconnd edition. DF=degrees of freedom. MSE=mean square error. 
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predicting neurological, motor proficiency, and 
neurocognitive impairment in a congruent manner over 
time. Therefore, we cannot conclusively establish that 
these processes are all associated with the same common 
mechanism that causes konzo, together comprising the 
syndrome of konzo. Elucidation of this mechanism is an 
important objective for future research characterising 
konzo in children.
Our baseline and present follow-up findings that boys 
with konzo (but not the girls) have worse cognitive 
proficiency than their counterparts without konzo is in 
contrast with a previously published report with a 
subgroup of our baseline cohorts.12 This previous report 
modelled cognitive performance (KABC-II scores) and 
motor proficiency (BOT-2) to serum levels of free thyroxine 
(free T4), thyroid-stimulating hormone (TSH), and 
albumin in 40 children with and without konzo, and 
concluded that girls were more at risk for cognitive 
deficits.12 Data in that study indicated that girls had lower 
KABC-II overall cognitive performance (MPI) than boys. 
This finding does not contradict our present study 
findings because in Bumoko and colleagues’ study,12 only 
the main effects of sex and konzo status were presented. 
Interactions are mentioned in the analysis section but not 
Figure 3: Change in KABC-II MPI cognitive performance and change in urinary thiocyanate between baseline and 4-year followup 
Change in urinary thiocyanate and change in KABC-II MPI score for (A) boys with konzo and (B) girls with konzo. KABC-II=Kaufman Assessment Battery for Children, 
second edition. MPI=Mental Processing Index. DF=degrees of freedom. MSE=mean square error. 
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in the results. As evidenced in tables 4 and 5 in the present 
study, the pattern of means is consistent with Bumoko 
and colleagues’ study;12 at intake girls had mean KABC-II 
MPI overall cognitive performance scores in the range 
of 50–60, whereas boys had mean scores in the range 
of 60–70. Thus, girls have a lower performance and are 
also at heightened risk for neurocognitive disability from 
konzo when not adjusting for other factors such as 
socioeconomic status, HOME score, and education. In 
fact, a “basement” effect might be present in KABC-II 
assessment of the Kahemba girls with konzo that obscures 
the true difference with their counterparts without konzo, 
which could be a psychometric study limitation. 
Regardless, konzo affected KABC-II overall cognitive 
performance score differently according to gender—the 
effects of konzo were greater among boys. Despite the fact 
that boys with and without konzo overall have higher 
scores than the girls, there is a greater difference between 
the groups of boys with and without konzo compared with 
that difference among girls.
In terms of accounting for this gender difference in 
neurocognitive risk from konzo, we previously noted that 
boys with konzo were also less likely to be enrolled in 
school, perhaps because of social stigma associated with 
the disorder.4 This might have further contributed to 
their poorer neurocognitive performance as compared 
with their counterparts without konzo, and those 
findings are supported in the present follow-up study as 
well. We also verified in our follow-up assessments that 
both the children with and without konzo were 
significantly below KABC cognitive ability normative 
performance of children from an area without konzo. 
These differences were especially apparent on sequential 
processing (memory) subtests. Another significant 
limitation in the present follow-up study, was that at 
2-year follow-up when performance differences between 
children with or without konzo as well as decline from 
baseline were strongest, we did not have samples of 
urinary thiocyanate from the study children, as were 
reported in the baseline study and at 4-year follow-up.
In our present follow-up study, children affected by 
konzo also had significantly lower anthropometric 
measures (weight for age, height for age), indicative of 
wasting and stunting. This could be because of the poor 
nutritional intake contributing to risk for konzo,20,21,22 and 
nutritional malabsorption from the direct effects of 
cassava toxicity on intestinal microbiota.5,23 In the present 
analyses, controlling for stunting (height-for-age Z score) 
resulted in non-significant between-group differences in 
the KABC-II outcomes of learning and overall 
performance (MPI) for the boys at 2-year follow-up. This 
suggests that stunting, often taken to be an indicator of 
more long-term chronic nutritional hardship (or 
malabsorption),19 might potentially mediate these 
cognitive differences between boys with and without 
konzo. This effect was not seen in the KABC-II domain 
of planning (reasoning), reported in an earlier study14 as a 
particularly robust cognitive outcome in a case study of 
more severely affected children with konzo.
The effects of dietary micronutrient deficiency should 
also be considered, such as thiamine deficiency, which 
has been associated with CNS signs similar to what is 
seen in konzo and warrants further pathogenic 
explorations. However, in view of what is known from 
the evidence about the probable neuropathogenic 
mechanisms of brain toxicity from cyanogenic toxins in 
poorly processed cassava, the neurocognitive effects of 
thiamine and other vitamin deficiencies in konzo are 
likely to be secondary to these.2,13 Regardless, the role of 
such micronutrient deficiencies as they relate to the 
direct neuropathogenic processes from cassava cyanogen 
exposure in nutritionally at-risk children with konzo is a 
key priority for future research, particularly because 
these factors relate to gender differences for konzo risk 
and progression.
As was the case in our baseline paper,4 most of the 
caregivers for both the konzo and control groups in our 
follow-up were affected by konzo, but a higher percentage 
of caregivers of children with konzo were affected. 
Caregivers affected by konzo would also be less able to 
provide for a quality caregiving environment for children 
with konzo, explaining the significantly reduced HOME 
scores for this group compared with the group without 
konzo. This is a further significant neurocognitive risk 
factor for children with konzo, not directly associated 
with the neuropathogenesis of toxic cassava.
Much of sub-Saharan Africa is becoming increasingly 
dependent on high-yield varieties of cassava that thrive in 
ecologically degraded zones and in conflict zones.24 
Therefore, continued brain or behaviour research that 
will help us better understand its neurotoxic properties is 
critical. The ability to document the more subtle CNS 
effects of cyanogenic toxicity with comprehensive and 
sensitive neuropsychological batteries is of major public 
health importance globally and more specifically, in 
African regions dependent on bitter cassava. Notably, 
boys with konzo significantly declined from baseline on 
KABC-II overall cognitive performance from baseline to 
2-year and even 4-year follow-up. This continued decline 
in boys could be the result of gender-specific effects of 
konzo disease noted in the previously published baseline 
study. The decline could also be the result of a poor 
neurocognitive trajectory of development and poor 
nutrition as compounded by konzo-induced disabilities.4 
Worse KABC cognitive performance and tactile-based 
learning over time has been documented in previous 
studies8,9,25,26 in this general region of Congo. These 
neuropsychological trajectories over time have been 
significantly associated with risk factors such as poor 
nutrition, physical growth, chronic helminths and 
malaria infection, anaemia, and ethnic groups living in 
village areas particularly at risk for these developmental 
impediments.9,27 When these factors are compounded by 
the functional neurodisabilities induced by konzo 
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disease, the community-wide economic and ecological 
effects on households can be devastating.28 Interventions 
to prevent further exposure to poorly processed cassava 
for children at risk of konzo are urgently needed, so as to 
prevent continued neuromotor and neurocognitive 
decline, such as the “wetting method” described by 
Bradbury and colleagues.29
To our knowledge, this study is the first attempt to 
characterise the cognitive and motor proficiency decline 
in children as they continue to subsist on bitter varieties 
of cassava as the main source of food. We have not only 
documented specific domains of continuing neuro-
cognitive deficits in children with konzo, especially boys, 
but have presented evidence for more pervasive 
neurocognitive effects (eg, memory) for both children 
with and without konzo in a similar nutritional 
environment with pervasive risk factors for konzo onset. 
Although we have documented changes in the 
neurocognitive and neuromotor proficiency of children 
with konzo and children at-risk without konzo, the 
pathophysiological and neurological progression of the 
disease itself in such children over time remains poorly 
understood. This is an important next-step in future 
research. However, what is clear is that in view of the 
ongoing neuropsychological risk from toxic cassava 
exposure in children in konzo-outbreak areas, 
interventions are urgently needed. Such interventions 
can use a peer-training model for simple and sustainable 
methods to detoxify the cassava flour (eg, wetting 
method), and thereby reduce the potential cumulative 
effects of toxin exposure on neurocognitive and 
neuromotor development over the long term. In view of 
the neurocognitive evidence in the present study, these 
public health benefits can occur even in the absence of 
abrupt neurological disease onset in at-risk children, as 
well as when confronted by chronic and possibly 
progressive neuromotor disability in children with konzo 
in communities dependent on toxic cassava.
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